Nifty

:

24085.70

Sensex

:

77155.62

96.55 (0.40%)
347.14 (0.45%)

Login

Nifty
Sensex

:
:

24085.70
77155.62

96.55 (0.40%)
347.14 (0.45%)

Dr Lalchandani Labs Ltd.

Hospital & Healthcare Services

Rating :

N/A

BSE: 541299 | NSE: Not Listed

Watchlist

NSE BSE

8.67

15-Jun-2026

Open
High
Low
Previous Close

8.77
8.88
8.45
9.38

Volume
Traded Value (lacs)
52 Week High
52 Week Low

144000
1228720
21.22
8.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7.49
118.86
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8.26
N/A
0.53

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-

P:BV (Average)

8 Years
5 Years
3 Years

-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales - 4.45 4.81 5.04 11.28 9.78 6.10 5.26 2.79 Net Sales Growth - -7.48% -4.56% -55.32% 15.34% 60.33% 15.97% 88.53% Cost Of Goods Sold - 0.96 2.06 1.21 2.98 3.61 1.15 0.61 0.63 Gross Profit - 3.50 2.75 3.83 8.30 6.17 4.96 4.66 2.16 GP Margin - 78.65% 57.17% 75.99% 73.58% 63.09% 81.31% 88.59% 77.42% Total Expenditure - 3.53 4.65 4.95 8.81 7.53 4.84 4.06 2.17 Power & Fuel Cost - 0.10 0.11 0.11 0.16 0.11 0.11 0.11 0.07 % Of Sales - 2.25% 2.29% 2.18% 1.42% 1.12% 1.80% 2.09% 2.51% Employee Cost - 0.48 0.72 1.11 1.11 0.42 0.57 0.67 0.30 % Of Sales - 10.79% 14.97% 22.02% 9.84% 4.29% 9.34% 12.74% 10.75% Manufacturing Exp. - 0.67 0.43 0.38 1.07 1.20 0.92 0.68 0.48 % Of Sales - 15.06% 8.94% 7.54% 9.49% 12.27% 15.08% 12.93% 17.20% General & Admin Exp. - 1.27 0.98 2.00 3.48 2.09 2.02 1.99 0.70 % Of Sales - 28.54% 20.37% 39.68% 30.85% 21.37% 33.11% 37.83% 25.09% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 0.06 0.37 0.13 0.02 0.11 0.07 0.00 0.00 % Of Sales - 1.35% 7.69% 2.58% 0.18% 1.12% 1.15% 0% 0% EBITDA - 0.92 0.16 0.09 2.47 2.25 1.26 1.20 0.62 EBITDA Margin - 20.67% 3.33% 1.79% 21.90% 23.01% 20.66% 22.81% 22.22% Other Income - 0.01 0.28 0.00 0.00 0.00 0.00 0.01 0.03 Interest - 0.09 0.38 0.99 0.60 0.35 0.18 0.14 0.16 Depreciation - 0.56 0.62 0.66 0.59 0.52 0.42 0.35 0.13 PBT - 0.28 -0.57 -1.56 1.29 1.38 0.66 0.72 0.35 Tax - -0.02 0.00 0.00 0.35 0.37 0.19 0.19 0.09 Tax Rate - -5.00% 0.00% 0.00% 27.13% 26.81% 28.79% 26.39% 25.71% PAT - 0.42 0.62 -1.56 0.93 1.01 0.47 0.53 0.26 PAT before Minority Interest - 0.42 0.62 -1.56 0.93 1.01 0.47 0.53 0.26 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 9.44% 12.89% -30.95% 8.24% 10.33% 7.70% 10.08% 9.32% PAT Growth - -32.26% - - -7.92% 114.89% -11.32% 103.85% EPS - 0.49 0.72 -1.81 1.08 1.17 0.55 0.62 0.30

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 9.96 9.54 8.92 10.49 9.55 8.54 8.07 3.33 Share Capital 4.33 4.33 4.33 4.33 4.33 4.33 4.33 2.93 Total Reserves 5.62 5.21 4.59 6.15 5.22 4.21 3.73 0.40 Non-Current Liabilities 0.13 0.42 3.48 2.78 2.77 1.54 0.65 1.32 Secured Loans 0.00 0.00 1.21 1.43 1.62 0.97 0.00 0.58 Unsecured Loans 0.00 0.26 2.10 1.19 1.02 0.49 0.60 0.71 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 5.66 5.03 5.32 4.86 2.87 1.86 1.42 1.56 Trade Payables 0.96 1.23 1.34 1.43 0.96 1.12 0.68 0.69 Other Current Liabilities 0.62 0.66 2.62 1.72 0.84 0.53 0.53 0.75 Short Term Borrowings 4.07 3.14 1.37 1.42 0.76 0.05 0.05 0.05 Short Term Provisions 0.02 0.00 0.00 0.29 0.31 0.16 0.16 0.07 Total Liabilities 15.75 14.99 17.72 18.13 15.19 11.94 10.14 6.21 Net Block 3.51 3.99 5.39 5.75 5.24 3.47 3.28 2.06 Gross Block 7.35 7.27 8.05 7.74 6.65 4.35 3.76 2.19 Accumulated Depreciation 3.84 3.28 2.65 1.99 1.40 0.88 0.48 0.13 Non Current Assets 4.88 5.51 6.70 7.21 6.40 4.03 3.84 2.41 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.27 0.41 0.24 0.24 0.24 0.24 0.24 0.24 Long Term Loans & Adv. 1.11 1.11 1.07 1.22 0.92 0.32 0.32 0.11 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 10.87 9.48 11.02 10.80 8.56 7.56 5.85 3.71 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1.29 1.44 1.52 1.56 0.68 0.50 0.39 0.27 Sundry Debtors 5.26 4.70 4.97 4.22 3.98 3.33 1.83 1.14 Cash & Bank 3.30 2.29 3.10 3.53 2.89 2.25 2.02 0.91 Other Current Assets 1.03 0.00 0.01 0.02 1.01 1.48 1.60 1.39 Short Term Loans & Adv. 1.02 1.05 1.42 1.48 0.99 1.48 1.59 1.38 Net Current Assets 5.21 4.45 5.70 5.94 5.69 5.70 4.42 2.15 Total Assets 15.75 14.99 17.72 18.12 15.19 11.93 10.15 6.20

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 0.37 -0.22 0.00 2.01 1.19 -0.10 -0.45 0.58 PBT 0.40 0.62 -1.56 1.29 1.38 0.66 0.72 0.35 Adjustment 0.64 0.81 1.54 1.07 0.69 0.42 0.35 0.29 Changes in Working Capital -0.68 -1.64 0.03 -0.02 -0.57 -1.02 -1.45 -0.06 Cash after chg. in Working capital 0.37 -0.22 0.00 2.33 1.50 0.06 -0.38 0.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -0.33 -0.31 -0.16 -0.07 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.06 1.00 -0.20 -1.53 -2.26 -0.53 -1.95 -1.29 Net Fixed Assets -0.08 0.78 -0.31 -1.09 -2.30 -0.59 -1.57 Net Investments 0.14 -0.17 0.00 0.00 0.00 0.00 0.00 Others 0.00 0.39 0.11 -0.44 0.04 0.06 -0.38 Cash from Financing Activity 0.58 -1.59 -0.23 0.16 1.71 0.85 3.51 1.56 Net Cash Inflow / Outflow 1.00 -0.81 -0.43 0.64 0.64 0.23 1.12 0.85 Opening Cash & Equivalents 2.29 3.10 3.53 2.89 2.25 2.02 0.91 0.05 Closing Cash & Equivalent 3.30 2.29 3.10 3.53 2.89 2.25 2.02 0.91

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 16.96 21.98 20.56 23.90 21.48 18.88 17.53 11.03 ROA 2.71% 3.78% -8.72% 5.60% 7.46% 4.30% 6.53% 4.23% ROE 4.29% 6.70% -16.23% 9.49% 11.56% 6.01% 9.85% 8.11% ROCE 3.61% 7.07% -3.69% 13.07% 14.88% 9.17% 12.57% 10.06% Fixed Asset Turnover 0.61 0.63 0.64 1.57 1.78 1.50 1.77 1.27 Receivable days 408.23 366.94 332.44 132.62 136.38 154.12 102.96 149.45 Inventory Days 111.84 112.22 111.46 36.13 21.91 26.58 23.01 35.53 Payable days 416.84 227.85 416.11 146.80 105.53 287.38 91.94 139.10 Cash Conversion Cycle 103.23 251.32 27.79 21.96 52.76 -106.67 34.03 45.87 Total Debt/Equity 0.41 0.37 0.72 0.50 0.43 0.21 0.12 0.58 Interest Cover 5.71 2.61 -0.57 3.15 4.88 4.57 6.27 3.23

Top Investors:

anuraag gambhir

harshpaul singh takkar

laxmipat dudheria

luxmi kant gupta

suhith pundalika bangera

statsol research llp

Annual Reports:

News Update:

Dr Lalchandani Labs opens new strategic centre in New Delhi
29th May 2026, 11:42 AM

The company expects the new centre to generate business of around Rs 1 crore per annum, contributing positively to overall growth and market penetration
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback